Anticholinergic behavioral effect of phencyclidine

Area of Science:

• Neuroscience
• Pharmacology
• Behavioral Science

Background:

• Phencyclidine (PCP) is known to cause cognitive deficits.
• The precise neurochemical mechanisms underlying PCP's behavioral effects are not fully understood.

Purpose of the Study:

• To investigate the neurochemical basis of phencyclidine-induced spatial alternation impairment in rats.
• To determine if PCP's effects are mediated by the cholinergic system.

Main Methods:

• Rats were administered phencyclidine (PCP) and its effects on spatial alternation performance were assessed.
• The effects of antimuscarinic anticholinergics (scopolamine, atropine) and PCP derivatives (ketamine, cyclohexamine) were compared to PCP.
• The impact of muscarinic cholinergic agonists on PCP-induced impairment was evaluated.

Main Results:

• Phencyclidine (PCP) significantly impaired spatial alternation performance in rats.
• This impairment was mimicked by antimuscarinic anticholinergics and certain PCP derivatives.
• Muscarinic cholinergic agonists were found to antagonize the effects of PCP.

Conclusions:

• The spatial memory deficits induced by phencyclidine (PCP) are, at least in part, mediated by an anticholinergic mechanism.
• This research provides the first evidence attributing a specific mechanism to a behavioral effect of PCP.
• Findings suggest potential therapeutic targets for mitigating PCP-induced cognitive impairment.